인공 심폐 장치 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)
Heart-lung Machine Market Size, Share & Trends Analysis Report By Product (Capital Equipment, Consumables), By Application (Coronary Artery Bypass Grafting, Heart Valve Surgeries), By End Use, By Region, And Segment Forecasts, 2026 - 2033
상품코드
:
1941495
리서치사
:
Grand View Research
발행일
:
2026년 01월
페이지 정보
:
영문 150 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
인공 심폐 장치 시장 개요
세계의 인공 심폐 장치 시장 규모는 2025년 22억 4,000만 달러로 추정되며, 2033년에 36억 7,000만 달러에 이를 것으로 예측됩니다.
또한 2026-2033년 연평균 6.36% 성장할 것으로 예측됩니다. 심혈관 질환 증가, 개흉 수술 건수 증가, 기술적으로 진보된 관류 시스템의 도입, 신흥 및 선진 지역의 의료시설 확대 등이 시장 성장을 견인하는 주요 요인입니다.
2025년 10월, Cleveland Clinic은 이식 전 기증자 폐의 평가 및 보존을 목적으로 인공심폐 기술과 기능적으로 연동되는 관류 기반 시스템인 체외 폐관류(EVLP)의 진보를 강조했습니다.
심장 및 폐 이식 프로그램의 확대에 따라 인공심폐 장치 및 관련 소모품을 포함한 고도의 관류 및 체외순환 지원 기술에 대한 수요가 증가하고 있습니다. 2025년 2월, 미국 이식학회지(American Journal of Transplantation)는 2023년 미국 내 성인 심장 이식 건수가 4,092건으로 2012년 대비 101.1% 증가했다고 보고했습니다. 대기자 명단 사망률은 환자 100명당 연간 8.5건으로 감소했습니다. 소아 심장 이식도 36.3% 증가했지만 이식률은 14.9% 감소했고, 이식 후 5년 생존율은 성인 80.3%, 소아 84.4%로 나타났습니다. 2023년 성인 심장 이식률은 환자 상태에 따라 다르며, 임상 상태와 이식 필요성에 따라 긴급도가 높은 순서대로 1등급(가장 긴급한 상태)부터 6등급(가장 덜 긴급한 상태)까지 분류했습니다.
의료기기 제조업체와 병원 간의 협력은 프로토타입에서 임상 적용까지의 시간을 단축하기 때문에 인공심폐장치 시장의 성장을 견인하는 주요 요인입니다. LivaNova PLC, Getinge AB와 같은 주요 제조업체 및 관류 전문 기업들은 심장센터와 협력하여 새로운 인공심폐 장치 및 ECMO 플랫폼을 실제 임상 환경에서 검증하기 위해 표적화된 임상시험 및 규제 대응 프로그램을 시행하고 있습니다. 규제 마일스톤 달성 및 초기 임상 데이터 생성은 보다 광범위한 조달 및 병원 도입에 직접적인 도움이 될 것입니다. 2025년 12월, NHS 웨일즈 공유 서비스 파트너십은 카디프 앤 베일 대학 의료위원회의 심흉부외과 부서를 지원하는 인공심폐 장치 및 자가 수혈 시스템 유지보수에 대해 리바노바 UK 리미티드와 서비스 계약을 체결하였습니다. 계약 기간은 2025년 9월부터 2026년 8월까지입니다.
또한, 산업은 큰 변화의 시기를 맞이하고 있습니다. 이러한 시스템은 개흉술 및 복잡한 흉부 수술에 필수적이지만, 수술 기술의 발전, 자동화 및 환자 관리의 발전으로 그 용도가 재정의되고 있습니다. 병원과 수술센터에서는 임상 결과 개선, 관류 시간 단축, 출혈량 최소화를 실현하는 새로운 플랫폼을 도입하여 정밀의료와 최소침습적 심장 치료로의 전환을 지원하고 있습니다. 2025년 10월, 스탠포드대학교 의료부는 로봇 보조 수술과 최소침습 관상동맥우회술(MIDCAB)을 포함한 최소침습 관상동맥우회술(CABG) 프로그램을 확대하여 환자의 회복 기간 단축과 통증 감소를 실현했습니다.
또한, 심폐우회술(CPB) 기술의 인지도 향상과 보급이 인공심폐장치 시장의 성장을 견인하고 있습니다. 병원과 심장센터에서는 복잡한 수술 중 순환과 산소 공급을 정밀하게 제어할 수 있는 현대식 CPB의 장점을 점점 더 많이 인식하고 있으며, 개선된 펌프, 산소화 장치, 통합 모니터링 시스템을 갖춘 인공 심폐 장치를 도입하고 있습니다. 이러한 추세는 수술 효율성과 환자 안전 향상을 목표로 하는 3차 의료시설과 고주파 심장센터에서 특히 두드러지게 나타나고 있습니다. 2025년 7월부터 8월까지 이란에서 실시된 횡단적 연구에서 관상동맥우회술(CABG) 후 환자 138명을 대상으로 높은 인지, 적극적 태도, 자기 관리 행동이 보고되었습니다. 이 연구는 교육과 표적화된 간호 개입이 자기 관리 능력과 회복 결과를 크게 향상시킨다는 점을 강조하고 있습니다.
목차 제1장 조사 방법과 범위
제2장 주요 요약
제3장 세계의 인공 심폐 장치 시장 변수, 동향, 범위
제4장 세계의 인공 심폐 장치 시장 세분화 분석(제품별, 2021-2033년)(단위 : 100만 달러)(단위 수량)
제5장 세계의 인공 심폐 장치 시장 세분화 분석, 용도별, 2021-2033년, 단위 : 100만 달러
제6장 세계의 인공 심폐 장치 시장 세분화 분석, 최종 용도별, 2021-2033년
제7장 지역별 인공 심폐 장치 시장 세분화 분석, 2021-2033년
제8장 경쟁 구도
LSH
영문 목차
Heart-lung Machine Market Summary
The global heart-lung machine market size was estimated at USD 2.24 billion in 2025 and is projected to reach USD 3.67 billion by 2033, growing at a CAGR of 6.36% from 2026 to 2033. The increasing burden of cardiovascular diseases, the rising number of open-heart surgeries, the adoption of technologically advanced perfusion systems, and the expansion of healthcare facilities in both emerging and developed regions are key aspects driving the market's growth.
In October 2025, Cleveland Clinic highlighted advances in ex vivo lung perfusion (EVLP), a perfusion-based system functionally aligned with heart-lung machine technologies, to assess and preserve donor lungs before transplantation.
The growth of heart and lung transplant programs is driving rising demand for advanced perfusion and extracorporeal support technologies, including heart-lung machines and associated consumables. In February 2025, the American Journal of Transplantation reported that U.S. adult heart transplants reached 4,092 in 2023, a 101.1% increase since 2012, with waitlist mortality falling to 8.5 deaths per 100 patient-years. Pediatric heart transplants also rose 36.3%, although the transplant rate declined 14.9%, and 5-year post-transplant survival rates were 80.3% for adults and 84.4% for children.In 2023, adult heart transplant rates varied by patient status, with Status 1 to 6 ranging from the highest urgency (Status 1) to the least urgent (Status 6), based on clinical condition and transplant need.
Collaboration between device manufacturers and hospitals is the prominent driver of growth in the heart-lung machine market, as it reduces the time from prototype to clinical use. Major manufacturers and specialist perfusion companies, such as LivaNova PLC and Getinge AB, conduct targeted clinical trials and regulatory programs in collaboration with cardiac centers to validate new cardiopulmonary bypass and ECMO platforms in real-world settings. Achieving regulatory milestones and generating early clinical data directly support broader procurement and hospital adoption. In December 2025, NHS Wales Shared Services Partnership entered into a service agreement with LivaNova UK Limited for the maintenance of heart-lung machines and autotransfusion systems supporting the Cardiothoracic Directorate at Cardiff & Vale University Health Board, covering the period from September 2025 to August 2026.
Moreover, the industry is undergoing significant change. These systems are essential for open-heart and complex thoracic procedures, while advances in surgical techniques, automation, and patient management are redefining their use. Hospitals and surgical centers are adopting new platforms that enhance clinical outcomes, reduce perfusion times, and minimize blood loss, supporting the shift toward precision-driven and minimally invasive cardiac care. In October 2025, Stanford Medicine expanded its minimally invasive coronary artery bypass grafting (CABG) program, which includes robotic-assisted and MIDCAB procedures, offering patients a faster recovery and reduced pain.
In addition, growing awareness and adoption of advanced cardiopulmonary bypass (CPB) techniques are driving the heart-lung machine market. Hospitals and cardiac centers are increasingly recognizing the benefits of modern CPB, which enables precise control of circulation and oxygenation during complex surgeries. This is prompting procurement of heart-lung machines with improved pumps, oxygenators, and integrated monitoring systems. The trend is particularly pronounced in tertiary and high-volume cardiac centers, which aim to enhance surgical efficiency and patient safety. In July-August 2025, a cross-sectional study in Iran reported high levels of awareness, attitude, and self-care behaviors among 138 post-CABG patients, highlighting that education and targeted nursing interventions significantly improve self-management and recovery outcomes.
Global Heart-Lung Machine Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global heart-lung machine market report based on product, application, end use, and region:
Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Capital Equipment
Pumps
Heater-Cooler Units / Heat Exchange Systems
Monitoring Systems
Others
Consumables
Cannulas
By Product
Arterial Cannulas
Venous Cannulas
Cardioplegia Cannulas
Vent Cannulas
ECMO Cannulas
By Age Group
Adult
Pediatric
Oxygenators
By Product
Membrane Oxygenators
ECMO Oxygenators
Pediatric/Neonatal Oxygenators
Other Oxygenators
By Age Group
Adult
Pediatric
Blood Reservoirs & Filtration Systems
Tubing Sets & Circuits
Accessories & Consumables
Application Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Coronary Artery Bypass Grafting (CABG)
Heart Valve Surgeries
Heart Transplant
Lung Transplant
Others
End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
Public Healthcare Institutions
Private Healthcare Institutions
Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
North America
Europe
Germany
UK
Spain
Italy
France
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Chile
Colombia
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model I)
1.6.2. Unit volume estimation (Model II)
1.6.3. Data collection and sources
1.6.3.1. Secondary data collection
1.6.3.2. Primary market intelligence
1.6.3.2.1. In-Depth Interviews (IDIs)
1.6.4. Analytical framework
1.6.4.1. Step 1: Base Market Identification
1.6.4.2. Step 2: Unit Demand Calculation
1.6.5. Forecasting methodology
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understand market dynamics
1.9.2. Objective 2: Understand market estimates & forecasts
1.9.3. Objective 3: Analyze growth drivers, trends, and unit dynamics for heart lung machine
1.9.4. Objective 4: Understand attributes such as strategy framework & competitive landscape
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. Global Heart-lung Machine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rise in heart and lung transplantation and advanced heart/lung failure care
3.2.1.2. Technological collaborations and partnerships between device manufacturers and hospitals
3.2.1.3. Rising preference for minimally invasive surgery
3.2.1.4. Growing awareness and adoption of advanced cardiopulmonary bypass techniques
3.2.2. Market restraint analysis
3.2.2.1. Operational and procedural hurdles restrict advanced CABG techniques
3.2.2.2. Limited access to trained perfusionists and specialized staff
3.2.3. Market opportunity analysis
3.2.3.1. Growth in pediatric and neonatal cardiac surgery programs
3.2.3.2. Expansion of ECMO use and its synergy with the heart-lung machine market
3.2.4. Market challenge analysis
3.2.4.1. Stringent regulatory and quality compliance standards
3.2.4.2. Import dependency creates operational uncertainty for heart-lung machine adoption
3.3. Global Heart Lung Machine: Market Analysis Tools
3.3.1. Industry Analysis - Porter's Five Force Analysis
3.3.2. PESTLE Analysis
3.4. Technological innovations in heart-lung machines materials and cannula design
3.5. Case Study Analysis
3.6. Healthcare Infrastructure Developments
3.6.1. Case Study: Dominican Republic - A Growing Hub For Medtech Manufacturing In Latin America
3.7. Procurement & Distribution Landscape
3.8. Recent Product Approvals & Market Entry Updates
Chapter 4. Global Heart-lung Machine Market Segment Analysis, By Product, 2021 - 2033 (USD Million) (Unit Volume)
4.1. The chapter will include the following:
4.1.1. Market Value (USD Million), 2021 - 2033
4.1.2. Unit Volume in '000 Units, 2021 - 2033
4.1.2.1. Capital Equipment, Existing Install Base, 2021 - 2033
4.1.2.2. Capital Equipment, New Install Base, 2021 - 2033
4.1.2.3. Consumables Unit Volume, 2021 - 2033
4.1.3. Growth Rates (% CAGR)
4.1.4. Data split by:
4.1.4.1. Global, 5 Regions, and 25 Countries
4.2. Definition and Scope
4.3. Heart-lung Machine Market Share Analysis, 2025 & 2033
4.4. Segment Dashboard
4.5. Heart-lung Machine Market By Product Outlook
4.6. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
4.7. Heart-lung Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8. Heart-lung Machine Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.1. Capital Equipment
4.8.1.1. Capital Equipment Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.1.2. Capital Equipment Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.1.3. Capital Equipment Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
4.8.1.4. Capital Equipment Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
4.8.1.4.1. Pumps
4.8.1.4.1.1. Pumps Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.1.5. Pumps Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
4.8.1.6. Pumps Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
4.8.1.6.1. Heater-Cooler Units / Heat Exchange Systems
4.8.1.6.1.1. Heater-Cooler Units / Heat Exchange Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.1.6.1.2. Heater-Cooler Units / Heat Exchange Systems Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
4.8.1.6.1.3. Heater-Cooler Units / Heat Exchange Systems Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
4.8.1.6.2. Monitoring Systems
4.8.1.6.2.1. Monitoring Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.1.6.2.2. Monitoring Systems Market (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
4.8.1.6.2.3. Monitoring Systems Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
4.8.1.6.3. Others
4.8.1.6.3.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.1.6.3.2. Others (Existing Installed Base), By Capital Equipment, 2021 - 2033 (In Thousand Units)
4.8.1.6.3.3. Others Market (New Unit Volume), By Capital Equipment, 2021 - 2033 (In Absolute Numbers)
4.8.2. Consumables
4.8.2.1. Consumables Machine Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2. Consumables Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.1. Oxygenators
4.8.2.2.1.1. Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.1.2. Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.2. By Product
4.8.2.2.3. Membrane Oxygenators
4.8.2.2.3.1. Membrane Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.3.2. Membrane Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.4. ECMO Oxygenators
4.8.2.2.4.1. ECMO Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.4.2. ECMO Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.5. Pediatric/Neonatal Oxygenators
4.8.2.2.5.1. Pediatric/Neonatal Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.5.2. Pediatric/Neonatal Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.6. Other Oxygenators
4.8.2.2.6.1. Other Oxygenators Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.6.2. Other Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.7. By Age Group
4.8.2.2.8. Adult
4.8.2.2.8.1. Adult Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.8.2. Adult Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.9. Pediatric
4.8.2.2.9.1. Pediatric Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.9.2. Pediatric Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.10. Cannulas
4.8.2.2.10.1. Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.10.2. Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.11. By Product
4.8.2.2.12. Arterial Cannulas
4.8.2.2.12.1. Arterial Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.12.2. Arterial Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.13. Venous Cannulas
4.8.2.2.13.1. Venous Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.13.2. Venous Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.14. Cardioplegia Cannulas
4.8.2.2.14.1. Cardioplegia Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.14.2. Cardioplegia Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.15. Vent Cannulas
4.8.2.2.15.1. Vent Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.15.2. Vent Cannulas Oxygenators Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.16. ECMO Cannulas
4.8.2.2.16.1. ECMO Cannulas Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.16.2. ECMO Cannulas Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.17. By Age Group
4.8.2.2.18. Adult
4.8.2.2.18.1. Adult Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.18.2. Adult Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.19. Pediatric
4.8.2.2.19.1. Pediatric Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.19.2. Pediatric Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.20. Blood Reservoirs & Filtration Systems
4.8.2.2.20.1. Blood Reservoirs & Filtration Systems Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.20.2. Blood Reservoirs & Filtration Systems Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.21. Tubing Sets & Circuits
4.8.2.2.21.1. Tubing Sets & Circuits Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.21.2. Tubing Sets & Circuits Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
4.8.2.2.22. Accessories & Consumables
4.8.2.2.22.1. Accessories & Consumables Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.8.2.2.22.2. Accessories & Consumables Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Chapter 5. Global Heart-lung Machine Market Segment Analysis, By Application, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. Definition and Scope
5.3. Application Market Share Analysis, 2025 & 2033
5.4. Segment Dashboard
5.5. Heart-lung Machine Market, By Application Outlook
5.6. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
5.6.1. Coronary Artery Bypass Grafting (CABG)
5.6.1.1. Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.6.2. Heart Valve Surgeries
5.6.2.1. Heart Valve Surgeries Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.6.3. Heart Transplant
5.6.3.1. Heart Transplant Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.6.4. Lung Transplant
5.6.4.1. Lung Transplant Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.6.5. Others
5.6.5.1. Others Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 6. Global Heart-lung Machine Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2025 & 2033
6.3. Segment Dashboard
6.4. Heart-lung Machine Market, By End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
6.5.1. Public Healthcare Institutions
6.5.1.1. Public Healthcare Institutions Market Estimates and Forecasts 2021 To 2033 (USD Million)
6.5.2. Private Healthcare Institutions
6.5.2.1. Private Healthcare Institutions Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 7. Heart-lung Machine Market Segment Analysis, By Region, 2021- 2033 (USD Million)
7.1. For each country/region, the final report will provide:
7.1.1. Market size & forecast (Revenue in USD Million; Unit Volume in '000 Units)
7.1.2. Growth Rates (% CAGR)
7.1.3. Competitive Scenario
7.1.4. Regulatory & reimbursement landscape
7.2. Regional Market Share Analysis, 2025 & 2033
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Heart-lung Machine Market Share by Region, 2025 & 2033:
7.6. North America
7.6.1. North America Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.6.2. Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.6.3. U.S.
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory Scenario & reimbursement scenario
7.6.3.3. Competitive Scenario
7.6.3.4. U.S. Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.6.3.5. U.S. Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.6.4. Canada
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory Scenario & reimbursement scenario
7.6.4.3. Competitive Scenario
7.6.4.4. Canada Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.6.4.5. Canada Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.6.5. Mexico
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory Scenario & reimbursement scenario
7.6.5.3. Competitive Scenario
7.6.5.4. Mexico Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.6.5.5. Mexico Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7. Europe
7.7.1. Europe Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.2. Europe Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.3. UK
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory Scenario & reimbursement scenario
7.7.3.3. Competitive Scenario
7.7.3.4. UK Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.3.5. UK Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.4. Germany
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory Scenario & reimbursement scenario
7.7.4.3. Competitive Scenario
7.7.4.4. Germany Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.4.5. Germany Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.5. France
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory Scenario & reimbursement scenario
7.7.5.3. Competitive Scenario
7.7.5.4. France Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.5.5. France Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.6. Italy
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory Scenario & reimbursement scenario
7.7.6.3. Competitive Scenario
7.7.6.4. Italy Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.6.5. Italy Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.7. Spain
7.7.7.1. Key country dynamics
7.7.7.2. Regulatory Scenario & reimbursement scenario
7.7.7.3. Competitive Scenario
7.7.7.4. Spain Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.7.5. Spain Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.8. Norway
7.7.8.1. Key country dynamics
7.7.8.2. Regulatory Scenario & reimbursement scenario
7.7.8.3. Competitive Scenario
7.7.8.4. Norway Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.8.5. Norway Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.9. Sweden
7.7.9.1. Key country dynamics
7.7.9.2. Regulatory Scenario & reimbursement scenario
7.7.9.3. Competitive Scenario
7.7.9.4. Sweden Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.9.5. Sweden Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.7.10. Denmark
7.7.10.1. Key country dynamics
7.7.10.2. Regulatory Scenario & reimbursement scenario
7.7.10.3. Competitive Scenario
7.7.10.4. Denmark Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.7.10.5. Denmark Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8. Asia Pacific
7.8.1. Asia Pacific Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.2. Asia Pacific Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.3. Japan
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory Scenario & reimbursement scenario
7.8.3.3. Competitive Scenario
7.8.3.4. Japan Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.3.5. Japan Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.4. China
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory Scenario & reimbursement scenario
7.8.4.3. Competitive Scenario
7.8.4.4. China Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.4.5. China Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.5. India
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory Scenario & reimbursement scenario
7.8.5.3. Competitive Scenario
7.8.5.4. India Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.5.5. India Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.6. Australia
7.8.6.1. Key country dynamics
7.8.6.2. Regulatory Scenario & reimbursement scenario
7.8.6.3. Competitive Scenario
7.8.6.4. Australia Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.6.5. Australia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.7. South Korea
7.8.7.1. Key country dynamics
7.8.7.2. Regulatory Scenario & reimbursement scenario
7.8.7.3. Competitive Scenario
7.8.7.4. South Korea Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.7.5. South Korea Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.8.8. Thailand
7.8.8.1. Key country dynamics
7.8.8.2. Regulatory Scenario & reimbursement scenario
7.8.8.3. Competitive Scenario
7.8.8.4. Thailand Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.8.8.5. Thailand Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.9. Latin America
7.9.1. Latin America Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.9.2. Latin America Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.9.3. Brazil
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory Scenario & reimbursement scenario
7.9.3.3. Competitive Scenario
7.9.3.4. Brazil Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.9.3.5. Brazil Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.9.4. Chile
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory Scenario & reimbursement scenario
7.9.4.3. Competitive Scenario
7.9.4.4. Chile Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.9.4.5. Chile Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.9.5. Colombia
7.9.5.1. Key country dynamics
7.9.5.2. Regulatory Scenario & reimbursement scenario
7.9.5.3. Competitive Scenario
7.9.5.4. Colombia Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.9.5.5. Colombia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.9.6. Argentina
7.9.6.1. Key country dynamics
7.9.6.2. Regulatory Scenario & reimbursement scenario
7.9.6.3. Competitive Scenario
7.9.6.4. Argentina Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.9.6.5. Argentina Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.10. Middle East and Africa
7.10.1. Middle East and Africa Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.10.2. Middle East and Africa Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.10.3. South Africa
7.10.3.1. Key country dynamics
7.10.3.2. Regulatory Scenario & reimbursement scenario
7.10.3.3. Competitive Scenario
7.10.3.4. South Africa Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.10.3.5. South Africa Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.10.4. Saudi Arabia
7.10.4.1. Key country dynamics
7.10.4.2. Regulatory Scenario & reimbursement scenario
7.10.4.3. Competitive Scenario
7.10.4.4. Saudi Arabia Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.10.4.5. Saudi Arabia Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.10.5. UAE
7.10.5.1. Key country dynamics
7.10.5.2. Regulatory Scenario & reimbursement scenario
7.10.5.3. Competitive Scenario
7.10.5.4. UAE Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.10.5.5. UAE Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
7.10.6. Kuwait
7.10.6.1. Key country dynamics
7.10.6.2. Regulatory Scenario & reimbursement scenario
7.10.6.3. Competitive Scenario
7.10.6.4. Kuwait Heart-lung Machine Market, 2021 - 2033 (USD Million)
7.10.6.5. Kuwait Heart-lung Machine Market estimates and forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization (Key innovators, market leaders, emerging players)
8.3. Company Market Position Analysis, 2025
8.4. Estimated Company Market Share Analysis, 2024/2025 (%)
8.5. Company Profiles
8.5.1. Medtronic
8.5.1.1. Company overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. Terumo Corporation
8.5.2.1. Company overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. LivaNova PLC
8.5.3.1. Company overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Getinge AB
8.5.4.1. Company overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Braille Biomedica
8.5.5.1. Company overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Nipro Corporation do Brasil (NIPRO)
8.5.6.1. Company overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Surge Cardiovascular
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. EUROSETS
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Technowood America Corporation
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Fresenius Medical Care
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
8.5.11. MERA (Senko Medical Instrument Mfg. Co., Ltd.)
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives
관련자료
